Add BrightSurf on Google Email

Lymphoma therapy could deliver a double punch

Researchers have discovered a CD19-dependent pathway that contributes to the growth of B cell lymphomas. High levels of CD19 correlate with increased MYC activity, suggesting a new target for therapies currently in clinical trials.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 30, 2012

DNA-repair machine maintains genomic stability

Mouse cells lacking nonhomologous DNA end-joining (NHEJ) pathway show high levels of chromosome breakage and genetic material rearrangement, highlighting its critical role in maintaining genomic stability. The study also reveals that NHEJ is essential for repairing damaged chromosomes induced by ionizing radiation.

SourceHoward Hughes Medical Institute·JournalProceedings of the National Academy of Sciences·DateJun 5, 2000